Tyra Biosciences Announces Participation at Upcoming Investor Events

CARLSBAD, Calif., Nov. 12, 2025 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: Jefferies London Healthcare ConferenceFormat: Hybrid presentation (slides &… Continue reading Tyra Biosciences Announces Participation at Upcoming Investor Events

Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update

LOS ANGELES, Nov. 12, 2025 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its third quarter ended September 30, 2025, and provided a corporate update.… Continue reading Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update

Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast

BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day,… Continue reading Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc. Cash and investments at September 30, 2025 were $21.3 million; combined with conditional future tranches of previous financings, expect sufficient cash through a potential PMA approval of Niyad in late 2026 5 of the 9 target profile clinical sites are now… Continue reading Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Rollins, Inc. Announces Closing of Secondary Public Offering of Common Stock

ATLANTA, Nov. 12, 2025 /PRNewswire/ — Rollins, Inc. (NYSE: ROL) (“Rollins” or the “Company”) today announced the closing of the previously announced secondary public offering of 17,391,305shares of its common stock, which included 2,608,695 shares sold pursuant to the underwriters’ exercise in full of an option (the “Offering”), by LOR, Inc. and Rollins Holding Company, Inc., two… Continue reading Rollins, Inc. Announces Closing of Secondary Public Offering of Common Stock

OAGi and NIIMBL Announce Release of Biopharmaceutical Manufacturing Ontologies to Advance Interoperability and Analytics

NEWARK, Del. and ATLANTA, Nov. 12, 2025 /PRNewswire/ — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to announce the release of a groundbreaking set of ontologies designed to enhance data interoperability and analytics capabilities across the biopharmaceutical industry. These ontologies are the result of a… Continue reading OAGi and NIIMBL Announce Release of Biopharmaceutical Manufacturing Ontologies to Advance Interoperability and Analytics

WinWire Named Finalist in the 2025 Microsoft Partner of the Year Awards for Modern Workplace for Frontline Workers

Accelerating Oncology Therapeutics and Revolutionizing Operations through Intelligent, AI-Powered Frontline Solutions SANTA CLARA, Calif., Nov. 12, 2025 /PRNewswire/ — WinWire today announced it has been named a finalist in the Modern Workplace for Frontline Workers category of the 2025 Microsoft Partner of the Year Awards for delivering measurable outcomes on Microsoft Cloud for a large… Continue reading WinWire Named Finalist in the 2025 Microsoft Partner of the Year Awards for Modern Workplace for Frontline Workers

FIEE Announces Fiscal 2025 Third Quarter Unaudited Financial Results

First Nine Months Revenue Increased Significantly by over 2 10 % YoY  Dual growth engine from MCN Digital Services and Customized Software R&D Services HONG KONG, Nov. 12, 2025 /PRNewswire/ — FiEE, Inc. (NASDAQ:FIEE) (“FiEE” or the “Company”), a technology company integrating IoT, connectivity and AI to redefine brand management solutions in the digital era, today… Continue reading FIEE Announces Fiscal 2025 Third Quarter Unaudited Financial Results

Innovation mit Offenheit voranbringen − Huawei veranstaltet das 6. Forum für Innovation und geistiges Eigentum

PEKING, 12. November 2025 /PRNewswire/ — Am 11. November 2025 veranstaltete Huawei sein sechstes Forum für Innovation und geistiges Eigentum, auf dem das Unternehmen die Gewinner seiner zweimal im Jahr vergebenen Auszeichnung „Top Ten Inventions” bekannt gab. Auf der Veranstaltung kamen Experten für Innovation und geistiges Eigentum aus der ganzen Welt zusammen, um die Bedeutung… Continue reading Innovation mit Offenheit voranbringen − Huawei veranstaltet das 6. Forum für Innovation und geistiges Eigentum

L’ouverture au service de l’innovation — Huawei organise son 6e Forum sur l’innovation et la propriété intellectuelle

PÉKIN, 12 novembre 2025 /PRNewswire/ — Le 11 novembre 2025, Huawei a tenu son sixième Forum sur l’innovation et la propriété intellectuelle (PI), au cours duquel l’entreprise a annoncé les lauréats de son prix bisannuel « Dix meilleures inventions ». Cet événement a rassemblé des spécialistes en innovation et en propriété intellectuelle du monde entier, venus examiner l’importance de… Continue reading L’ouverture au service de l’innovation — Huawei organise son 6e Forum sur l’innovation et la propriété intellectuelle